One-Year Outcomes After Conversion Bariatric Surgery

February 2, 2026 updated by: Seher Şen, Medipol University

ONE-YEAR OUTCOMES OF ANTHROPOMETRIC, BIOCHEMICAL, AND NUTRITIONAL PARAMETERS AFTER CONVERSION BARIATRIC SURGERY

Obesity is a growing global public health problem, and bariatric surgery is currently the most effective treatment for achieving sustained weight loss and improving obesity-related comorbidities. However, a subset of patients experience inadequate weight loss or weight regain following primary bariatric surgery, which may lead to the recurrence of metabolic complications and reduced quality of life. In such cases, conversion bariatric surgery, defined as the surgical conversion from one bariatric procedure to another, is considered an important therapeutic option. Despite the increasing number of conversion procedures, comprehensive longitudinal data evaluating anthropometric, biochemical, and nutritional outcomes after conversion bariatric surgery remain limited.

This study aims to prospectively evaluate individuals undergoing conversion bariatric surgery due to weight regain following primary bariatric surgery. Anthropometric measurements, biochemical parameters, and nutritional status will be assessed preoperatively and at 1 year after surgery. By evaluating weight loss outcomes together with metabolic and nutritional changes, this study seeks to provide clinically relevant evidence to guide postoperative follow-up strategies, optimize nutritional management, and support multidisciplinary care in patients undergoing conversion bariatric surgery.

Study Overview

Status

Active, not recruiting

Study Type

Observational

Enrollment (Estimated)

14

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bursa
      • Osmangazi, Bursa, Turkey (Türkiye), 16160
        • Mudanya Univesity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients aged 18-65 years who had previously undergone bariatric surgery and subsequently received conversion bariatric surgery due to suboptimal clinical response, defined as suboptimal weight loss or recurrent weight gain. Participants are followed in routine clinical practice and evaluated preoperatively and at postoperative 1 year for anthropometric, biochemical, nutritional, and physical activity outcomes.

Description

Inclusion Criteria:

  • Adults aged 18-45 years
  • Previously underwent bariatric surgery
  • Subsequently underwent conversion bariatric surgery due to suboptimal clinical response

Suboptimal clinical response defined as either:

  • Suboptimal Clinical Response (SCR): maximum total weight loss (TWL%) of <20% within 18 months after metabolic and bariatric surgery
  • Recurrent Weight Gain (RWG): regaining >30% of initial postoperative weight loss after achieving initial weight reduction

Exclusion Criteria:

  • Pregnancy or lactation
  • Presence of acute illness or infection
  • Comorbid conditions that could limit treatment efficacy or compromise safety
  • Participation in professional athletic activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Conversion Bariatric Surgery
This cohort includes patients who previously underwent conversion bariatric surgery as part of routine clinical care and were followed observationally. Anthropometric measurements, biochemical parameters, and nutritional status were assessed at the preoperative period and postoperative month 12 (1 year).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Composition Parameters
Time Frame: Preoperative baseline and postoperative 1 year
Body composition parameters including fat mass, fat percentage, fat-free mass, fat-free mass percentage, skeletal muscle mass, muscle percentage, and extracellular water to total body water ratio assessed using multi-frequency bioelectrical impedance analysis (BIA).
Preoperative baseline and postoperative 1 year
Change in Body Weight
Time Frame: Preoperative baseline and postoperative 1 year
Change in body weight (kg) measured using a digital scale with participants wearing light clothing and no shoes.
Preoperative baseline and postoperative 1 year
Change in Body Mass Index (BMI)
Time Frame: Preoperative baseline and postoperative 1 year
Change in body mass index (kg/m²) calculated from measured body weight and height.
Preoperative baseline and postoperative 1 year
Percentage of Total Weight Loss
Time Frame: postoperative 1 year
Percentage of total weight loss calculated as [(preoperative weight - postoperative weight) / preoperative weight] × 100.
postoperative 1 year
Percentage of Excess Weight Loss
Time Frame: postoperative 1 year
Percentage of excess weight loss calculated as [(preoperative weight - postoperative weight) / (preoperative weight - ideal body weight)] × 100, with ideal body weight defined as a BMI of 25 kg/m².
postoperative 1 year
Change in Waist Circumference
Time Frame: Preoperative baseline and postoperative 1 year
Waist circumference (cm) measured in the standing position using a non-elastic measuring tape at the midpoint between the lowest rib and the iliac crest.
Preoperative baseline and postoperative 1 year
Change in Hip Circumference
Time Frame: Preoperative baseline and postoperative 1 year
Hip circumference (cm) measured in the standing position at the point of maximum protrusion of the gluteal muscles using a non-elastic measuring tape.
Preoperative baseline and postoperative 1 year
Change in Body Fat Percentage (%)
Time Frame: Preoperative baseline and postoperative 1 year
Body fat percentage measured using multi-frequency bioelectrical impedance analysis (BIA).
Preoperative baseline and postoperative 1 year
Change in Fat-Free Mass (kg)
Time Frame: Preoperative baseline and postoperative 1 year
Fat-free mass measured using multi-frequency bioelectrical impedance analysis (BIA).
Preoperative baseline and postoperative 1 year
Change in Skeletal Muscle Mass (kg)
Time Frame: Preoperative baseline and postoperative 1 year
Skeletal muscle mass measured using multi-frequency bioelectrical impedance analysis (BIA).
Preoperative baseline and postoperative 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fasting Plasma Glucose
Time Frame: Preoperative baseline and postoperative 1 year
Changes in fasting plasma glucose levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Alanine Aminotransferase (ALT)
Time Frame: Preoperative baseline and postoperative 1 year
Changes in alanine aminotransferase (ALT) levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Hematological Parameters
Time Frame: Preoperative baseline and postoperative 1 year
Changes in hemoglobin and hematocrit levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Iron Status Parameters
Time Frame: Preoperative baseline and postoperative 1 year
Changes in serum ferritin, serum iron, and total iron-binding capacity levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Micronutrient and Electrolyte Levels
Time Frame: Preoperative baseline and postoperative 1 year
Changes in serum vitamin B12, folic acid, magnesium, total calcium, sodium, and potassium levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Fasting Insulin
Time Frame: Preoperative baseline and postoperative 1 year
Changes in fasting insulin levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Glycated Hemoglobin (HbA1c)
Time Frame: Preoperative baseline and postoperative 1 year
Changes in glycated hemoglobin (HbA1c) levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Total Cholesterol
Time Frame: Preoperative baseline and postoperative 1 year
Changes in total cholesterol levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in LDL Cholesterol
Time Frame: Preoperative baseline and postoperative 1 year
Changes in low-density lipoprotein (LDL) cholesterol levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in HDL Cholesterol
Time Frame: Preoperative baseline and postoperative 1 year
Changes in high-density lipoprotein (HDL) cholesterol levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Triglyceride Levels
Time Frame: Preoperative baseline and postoperative 1 year
Changes in triglyceride levels measured from venous blood samples
Preoperative baseline and postoperative 1 year
Change in Aspartate Aminotransferase (AST)
Time Frame: Preoperative baseline and postoperative 1 year
Changes in aspartate aminotransferase (AST) levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Urea Levels
Time Frame: Preoperative baseline and postoperative 1 year
Changes in serum urea levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year
Change in Uric Acid Levels
Time Frame: Preoperative baseline and postoperative 1 year
Changes in serum uric acid levels measured from venous blood samples.
Preoperative baseline and postoperative 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Seher Şen, Assistant Professor, Mudanya University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 12, 2024

Primary Completion (Actual)

January 10, 2026

Study Completion (Estimated)

February 21, 2026

Study Registration Dates

First Submitted

December 17, 2025

First Submitted That Met QC Criteria

January 8, 2026

First Posted (Actual)

January 15, 2026

Study Record Updates

Last Update Posted (Actual)

February 3, 2026

Last Update Submitted That Met QC Criteria

February 2, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to the need to protect patient privacy and confidentiality.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bariatric Surgery

Subscribe